33642990|t|Isoliquiritigenin Confers Neuroprotection and Alleviates Amyloid-beta42-Induced Neuroinflammation in Microglia by Regulating the Nrf2/NF-kappaB Signaling.
33642990|a|BACKGROUND: Neuroinflammation and oxidative stress are two major pathological characteristics of Alzheimer's disease (AD). Amyloid-beta oligomers (AbetaO), a toxic form of Abeta, promote the neuroinflammation and oxidative stress in the development of AD. Isoliquiritigenin (ISL), a natural flavonoid isolated from the root of liquorice, has been shown to exert inhibitory effects on inflammatory response and oxidative stress. OBJECTIVES: The main purpose of this study is to assess the influence of ISL on inflammatory response and oxidative stress in BV2 cells stimulated with AbetaO, and to explore the underlying molecular mechanisms. METHODS: 3-(4,5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H- tetrazolium bromide (MTT) and lactate dehydrogenase (LDH) cytotoxicity assays were used to assess the toxic or protective effects of ISL. The expression levels of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha were assessed by quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assays. Morphological changes in BV2 cells were assessed by immunofluorescence method. Nitric oxide (NO) assay kit was used to determinate the NO production. Western blot, qRT-PCR and immunofluorescence were used to explore the underlying molecular mechanisms. RESULTS: ISL treatment reduced the production of inflammatory cytokines and NO, and alleviated the morphological changes in BV2 cells induced by AbetaO. ISL treatment further protected N2a cells from the toxic medium of AbetaO-stimulated BV2 cells. ISL activated nuclear factor erythroid-2 related factor 2 (Nrf2) signaling and suppressed nuclear factor-kappaB (NF-kappaB) signaling in BV2 cells. CONCLUSION: ISL suppresses AbetaO-induced inflammation and oxidative stress in BV2 cells via the regulation of Nrf2/NF-kappaB signaling. Therefore, ISL indirectly protects neurons from the damage of toxic conditioned media.
33642990	0	17	Isoliquiritigenin	Chemical	MESH:C040920
33642990	57	71	Amyloid-beta42	Chemical	-
33642990	80	97	Neuroinflammation	Disease	MESH:D000090862
33642990	129	133	Nrf2	Gene	18024
33642990	134	143	NF-kappaB	Gene	18033
33642990	167	184	Neuroinflammation	Disease	MESH:D000090862
33642990	252	271	Alzheimer's disease	Disease	MESH:D000544
33642990	273	275	AD	Disease	MESH:D000544
33642990	313	318	toxic	Disease	MESH:D064420
33642990	327	332	Abeta	Gene	11820
33642990	346	363	neuroinflammation	Disease	MESH:D000090862
33642990	407	409	AD	Disease	MESH:D000544
33642990	411	428	Isoliquiritigenin	Chemical	MESH:C040920
33642990	430	433	ISL	Chemical	MESH:C040920
33642990	446	455	flavonoid	Chemical	MESH:D005419
33642990	539	551	inflammatory	Disease	MESH:D007249
33642990	656	659	ISL	Chemical	MESH:C040920
33642990	663	675	inflammatory	Disease	MESH:D007249
33642990	709	712	BV2	CellLine	CVCL:0182
33642990	804	871	3-(4,5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H- tetrazolium bromide	Chemical	MESH:C000598529
33642990	873	876	MTT	Chemical	-
33642990	910	922	cytotoxicity	Disease	MESH:D064420
33642990	954	959	toxic	Disease	MESH:D064420
33642990	985	988	ISL	Chemical	MESH:C040920
33642990	1015	1032	interleukin-1beta	Gene	16176
33642990	1034	1047	interleukin-6	Gene	16193
33642990	1053	1080	tumor necrosis factor-alpha	Gene	21926
33642990	1222	1225	BV2	CellLine	CVCL:0182
33642990	1276	1288	Nitric oxide	Chemical	MESH:D009569
33642990	1459	1462	ISL	Chemical	MESH:C040920
33642990	1574	1577	BV2	CellLine	CVCL:0182
33642990	1595	1602	AbetaO.	Chemical	-
33642990	1603	1606	ISL	Chemical	MESH:C040920
33642990	1635	1638	N2a	CellLine	CVCL:0470
33642990	1654	1659	toxic	Disease	MESH:D064420
33642990	1688	1691	BV2	CellLine	CVCL:0182
33642990	1699	1702	ISL	Chemical	MESH:C040920
33642990	1713	1756	nuclear factor erythroid-2 related factor 2	Gene	18024
33642990	1758	1762	Nrf2	Gene	18024
33642990	1789	1810	nuclear factor-kappaB	Gene	18033
33642990	1812	1821	NF-kappaB	Gene	18033
33642990	1836	1839	BV2	CellLine	CVCL:0182
33642990	1859	1862	ISL	Chemical	MESH:C040920
33642990	1889	1901	inflammation	Disease	MESH:D007249
33642990	1926	1929	BV2	CellLine	CVCL:0182
33642990	1958	1962	Nrf2	Gene	18024
33642990	1963	1972	NF-kappaB	Gene	18033
33642990	1995	1998	ISL	Chemical	MESH:C040920
33642990	2046	2051	toxic	Disease	MESH:D064420
33642990	Association	MESH:D007249	18033
33642990	Negative_Correlation	MESH:C040920	MESH:D000090862
33642990	Positive_Correlation	MESH:C040920	18024
33642990	Negative_Correlation	MESH:C040920	MESH:D064420
33642990	Negative_Correlation	MESH:C040920	18033
33642990	Negative_Correlation	MESH:C040920	MESH:D007249

